<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="table1" position="float"><label>Table 1.</label><caption><title>Potential therapeutic interventions, their targets, and predicted effect.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom">Drug</th><th valign="bottom">Target</th><th valign="bottom">Predicted Effect</th></tr></thead><tbody><tr><td>Danazol, Stanozolol</td><td>SERPING1</td><td>Reduce Bradykinin production</td></tr><tr><td>Icatibant</td><td>BKB2R</td><td>Reduce Bradykinin signaling</td></tr><tr><td>Ecallantide</td><td>KLKB1</td><td>Reduce Bradykinin production</td></tr><tr><td>Berinert,Cinryze,Haegarda</td><td>SERPING1</td><td>Reduce Bradykinin production</td></tr><tr><td>Vitamin D</td><td>REN</td><td>Reduce Renin production</td></tr><tr><td>Hymecromone</td><td>HAS1,HAS2, HAS3</td><td>Reduce hyaluronan</td></tr><tr><td>Timbetasin</td><td>TMSB4X</td><td>Increase fibrinolysis</td></tr></tbody></table></table-wrap>